Another study revealed the synergistic effect of triptolide and Nutlin-3a (an MDM2 inhibitor) in inhibiting cell proliferation and triggering mitochondrial-mediated apoptosis in vitro and ex vivo in wild-type p53 AML xenograft leukemia cells. This evidence concerns the gene MDM2 and leukemia.